Summit Therapeutics Inc
NASDAQ:SMMT
Earnings Announcements
Summit Therapeutics Reports Results For First Quarter Ended March 31, 2022
Published: 05/11/2022 22:40 GMT
Summit Therapeutics Inc (SMMT) - Summit Therapeutics Inc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2022.
Summit Therapeutics Inc - Qtrly Loss per Share $0.22.
Summit Therapeutics Inc - Qtrly Loss per Share $0.22.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.27
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.28
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.27
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.28
More details on our Analysts Page.